Intra-Cellular Therapies, Inc. (ITCI)

USD 131.87

(0.0%)

Total Debt Summary of Intra-Cellular Therapies, Inc.

  • Intra-Cellular Therapies, Inc.'s latest annual total debt in 2023 was 16.93 Million USD , down -15.48% from previous year.
  • Intra-Cellular Therapies, Inc.'s latest quarterly total debt in 2024 Q3 was 17.7 Million USD , down -3.17% from previous quarter.
  • Intra-Cellular Therapies, Inc. reported annual total debt of 20.04 Million USD in 2022, down -21.12% from previous year.
  • Intra-Cellular Therapies, Inc. reported annual total debt of 25.4 Million USD in 2021, down -12.82% from previous year.
  • Intra-Cellular Therapies, Inc. reported quarterly total debt of 17.7 Million USD for 2024 Q3, down -3.17% from previous quarter.
  • Intra-Cellular Therapies, Inc. reported quarterly total debt of 18.28 Million USD for 2024 Q2, up 11.68% from previous quarter.

Annual Total Debt Chart of Intra-Cellular Therapies, Inc. (2023 - 2012)

Historical Annual Total Debt of Intra-Cellular Therapies, Inc. (2023 - 2012)

Year Total Debt Total Debt Growth
2023 16.93 Million USD -15.48%
2022 20.04 Million USD -21.12%
2021 25.4 Million USD -12.82%
2020 29.14 Million USD 25.92%
2019 23.14 Million USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%

Peer Total Debt Comparison of Intra-Cellular Therapies, Inc.

Name Total Debt Total Debt Difference
Esperion Therapeutics, Inc. 540.94 Million USD 96.869%
Theratechnologies Inc. 58.96 Million USD 71.276%
Safety Shot Inc 1.54 Million USD -993.498%
Cosmos Health Inc. 12.42 Million USD -36.333%
Cronos Group Inc. 2.53 Million USD -566.867%
Ironwood Pharmaceuticals, Inc. 715.53 Million USD 97.633%
Kala Pharmaceuticals, Inc. 36.32 Million USD 53.368%
Organogenesis Holdings Inc. 119.35 Million USD 85.808%
Universe Pharmaceuticals INC 5.48 Million USD -208.949%
ProPhase Labs, Inc. 21.38 Million USD 20.776%
Sonoma Pharmaceuticals, Inc. 608 Thousand USD -2685.855%
Dynavax Technologies Corporation 256.91 Million USD 93.407%
Radius Health, Inc. 365.31 Million USD 95.363%
China SXT Pharmaceuticals, Inc. 2.64 Million USD -539.784%
Alvotech 1.07 Billion USD 98.425%
Sunshine Biopharma, Inc. 657.7 Thousand USD -2475.319%
Alpha Teknova, Inc. 30.45 Million USD 44.389%
SCYNEXIS, Inc. 15.08 Million USD -12.321%
Harrow Health, Inc. 190.5 Million USD 91.109%
Biofrontera Inc. 5.39 Million USD -213.725%
DURECT Corporation 20.74 Million USD 18.355%
Supernus Pharmaceuticals, Inc. 41.52 Million USD 59.212%
ANI Pharmaceuticals, Inc. 315.32 Million USD 94.628%
OptiNose, Inc. 131.74 Million USD 87.144%
RedHill Biopharma Ltd. 1.17 Million USD -1343.982%
Aquestive Therapeutics, Inc. 98.82 Million USD 82.86%
Cumberland Pharmaceuticals Inc. 18.42 Million USD 8.088%
SIGA Technologies, Inc. 1.46 Million USD -1056.96%
Lifecore Biomedical, Inc. 130.36 Million USD 87.007%
Shineco, Inc. 29.65 Million USD 42.886%
Phibro Animal Health Corporation 525.45 Million USD 96.777%
Procaps Group S.A. 285.93 Million USD 94.076%
TherapeuticsMD, Inc. 8 Million USD -111.593%
Regencell Bioscience Holdings Limited 59.8 Thousand USD -28221.1%
Viatris Inc. 18.12 Billion USD 99.907%
Sunshine Biopharma, Inc. 657.7 Thousand USD -2475.319%
Rockwell Medical, Inc. 13.43 Million USD -26.036%
Incannex Healthcare Limited 373 Thousand USD -4441.019%
Aytu BioPharma, Inc. 15.12 Million USD -11.957%
Tilray Brands, Inc. 387.31 Million USD 95.627%
Collegium Pharmaceutical, Inc. 674.28 Million USD 97.488%
PetIQ, Inc. 468.3 Million USD 96.383%
Silver Spike Investment Corp. - USD -Infinity%
Neurocrine Biosciences, Inc. 428.4 Million USD 96.046%
Journey Medical Corporation 17.73 Million USD 4.467%
Alimera Sciences, Inc. 67.39 Million USD 74.869%
Petros Pharmaceuticals, Inc. 8.27 Million USD -104.649%
Assertio Holdings, Inc. 40.91 Million USD 58.599%
Shuttle Pharmaceuticals Holdings, Inc. 1.08 Million USD -1457.239%
Embecta Corp. 1.63 Billion USD 98.966%
Cyclo Therapeutics, Inc. 1.03 Million USD -1539.508%
Procaps Group, S.A. 285.93 Million USD 94.076%
PainReform Ltd. 86 Thousand USD -19595.349%
Avadel Pharmaceuticals plc 35.38 Million USD 52.131%
Hempacco Co., Inc. 13.72 Million USD -23.414%
Talphera, Inc. - USD -Infinity%
Pacira BioSciences, Inc. 586.04 Million USD 97.11%
Alvotech 1.07 Billion USD 98.425%
Lantheus Holdings, Inc. 616.94 Million USD 97.255%
Kamada Ltd. 8.74 Million USD -93.6%
Indivior PLC 281.6 Million USD 93.985%
Currenc Group, Inc. 31.94 Million USD 46.975%
Evoke Pharma, Inc. 5 Million USD -238.76%
Flora Growth Corp. 3.67 Million USD -361.275%
Cyclo Therapeutics, Inc. 1.03 Million USD -1539.508%
Evolus, Inc. 126.54 Million USD 86.615%
HUTCHMED (China) Limited 86.13 Million USD 80.335%
Amphastar Pharmaceuticals, Inc. 623.64 Million USD 97.284%
Akanda Corp. 3.99 Million USD -323.578%